Health management services and diagnostics firm Alere recently updated investors on the progress of a pair of nucleic acid testing platforms that are currently under development at the company and represent the firm's entrée into molecular diagnostics.
Nanobiosys, a four-year-old South Korean molecular diagnostics firm, has published the first description and validation study of its flagship technology, a fast, portable, and inexpensive fluidic chip-based real-time PCR instrument.
Life Technologies announced this week that it has established a collaborative effort involving researchers from several public health organizations and other organizations to evaluate and adapt an Ion Torrent PGM protocol to sequence the influenza genome for flu tracking and vacc
NEW YORK (GenomeWeb News) – A pair of new PLoS ONE studies suggests specific gene expression signatures in host blood samples correspond with symptomatic viral and bacterial infections — information that may ultimately lead to more effective ways of detecting, tracking, and treating such
NEW YORK (GenomeWeb News) – Two research consortia will receive as much as $52.4 million from the National Institute of Allergy and Infectious Diseases to continue studies using structural genomics to characterize the structures of proteins from a number of dangerous bacterial, protozoan, and vir
Focus Diagnostics, a subsidiary of Quest Diagnostics, said this week that the US Food and Drug Administration has granted 510(k) clearance and CLIA moderate-complexity categorization to Focus' Simplexa Flu A/B & RSV direct test on the